Image de couverture de livre

Increased risk of infusion‐related reactions switching between monoclonal antibodies for Alzheimer's disease: A case series

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ganesh Gopalakrishna, Cristina Tandoc, Pallavi Joshi
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Mid‐ and late‐life depression increases risk of Alzheimer's disease and related dementias in veterans
par: Lay Kodama, et autres
Publié: (2026)

Standardization of criteria in MacCAT‐T and MacCAT‐CR for monoclonal anti–beta‐amyloid antibodies: A Delphi study
par: Jonas Karneboge, et autres
Publié: (2025)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
par: Iolanda Lázaro, et autres
Publié: (2024)

The relative contribution of modifiable and non‐modifiable factors for determining cognition in mid‐life individuals at risk for late‐life Alzheimer's disease
par: Bolin Cao, et autres
Publié: (2026)

Age‐related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community‐based cohort study
par: Chloe A. Krakauer, et autres
Publié: (2026)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
par: Darren M. Lipnicki, et autres
Publié: (2026)

Association between BrainAGE and Alzheimer's disease biomarkers
par: Yousaf Abughofah, et autres
Publié: (2025)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
par: Willa D. Brenowitz, et autres
Publié: (2026)

Examining the propensity and nature of criminal risk behaviours in frontotemporal dementia syndromes and Alzheimer's disease
par: Fiona Kumfor, et autres
Publié: (2024)

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
par: Sonja M. Kagerer, et autres
Publié: (2024)

Bayesian analyses for research on Alzheimer's disease and related disorders—updating one's knowledge
par: Stefan Teipel, et autres
Publié: (2025)

Peripheral oxidative stress related biomarkers in Alzheimer's disease: A systematic review of their implications for diagnosis and disease monitoring
par: George Nkrumah Osei, et autres
Publié: (2026)

Technology‐based instrumental activities of daily living in persons with Alzheimer's disease and related disorders
par: Jared F. Benge, et autres
Publié: (2024)

Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United States
par: Sephira Ryman, et autres
Publié: (2026)

Family history, perceived risk, and perceived threat of Alzheimer's disease among Latino residents of northern Manhattan
par: Eleanor J. Murphy, et autres
Publié: (2026)

BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease
par: Kyle J. Edmunds, et autres
Publié: (2025)

Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
par: Fang Wang, et autres
Publié: (2025)

Investigating the relationship between sleep disturbances and white matter hyperintensities in older adults on the Alzheimer's disease spectrum
par: Farooq Kamal, et autres
Publié: (2024)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
par: Gustavo Luis Verón, et autres
Publié: (2025)

The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome
par: Julianne G. Clina, et autres
Publié: (2026)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
par: María A. Rodríguez‐Santiago, et autres
Publié: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
par: Andrée‐Ann Baril, et autres
Publié: (2024)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
par: Thomas Claessen, et autres
Publié: (2025)

Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
par: Diana Esteller‐Gauxax, et autres
Publié: (2026)

Treating Alzheimer's disease in a person living with HIV
par: David B. Clifford, et autres
Publié: (2026)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
par: Samantha C. Burnham, et autres
Publié: (2026)

Diagnostic performance of light reflex pupillometry in Alzheimer's disease
par: Mathias Holsey Gramkow, et autres
Publié: (2024)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
par: Faheem Arshad, et autres
Publié: (2025)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
par: Miguel Ángel Rivas‐Fernández, et autres
Publié: (2026)

Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
par: Manuela Dicarlo, et autres
Publié: (2026)

Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease
par: Peter Thomas, et autres
Publié: (2024)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
par: Alisa Bannerjee, et autres
Publié: (2025)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
par: David Foxe, et autres
Publié: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
par: Sofia Toniolo, et autres
Publié: (2024)

Accuracy of pattern‐based dementia diagnostic protocols: Using longitudinal data to infer etiology of Alzheimer's disease and related dementias compared to stroke or normal aging
par: Sean A. P. Clouston, et autres
Publié: (2025)

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
par: Nicholas R. Ray, et autres
Publié: (2024)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
par: Katharina Bolsewig, et autres
Publié: (2024)

Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West
par: Bethany C. Curd, et autres
Publié: (2026)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
par: Ying Xia, et autres
Publié: (2025)

Machine learning models of Alzheimer's disease spectrum using blood tests
par: Nicola Walter Falasca, et autres
Publié: (2025)